ROIVANT

Class [005]
Pharmaceutical preparations for the treatment of infectious diseases, namely respiratory infections, eye infections, blood infections, skin infections, bladder infections, kidney infections, ear infections, sinus infections, dental infections, gastrointestinal infections, brain infections, spinal infections; pharmaceutical preparations for the treatment of viral diseases, namely viral respiratory infections, viral eye infections, viral blood infections, viral skin infections, viral bladder infections, viral kidney infections, viral ear infections, viral sinus infections, viral dental infections, viral gastrointestinal infections, viral brain infections, viral spinal infections; pharmaceutical preparations, namely antivirals; pharmaceutical preparations for use in oncology; pharmaceutical preparations for the treatment of immunologic diseases, namely, autoimmune diseases, immunologic deficiency syndromes; pharmaceutical preparations for the treatment of inflammatory diseases, namely inflammatory bowel diseases, inflammatory connective tissue diseases and injuries; pharmaceutical preparations for the treatment of diseases, disorders and infections of the endocrine system, namely growth and thyroid disorders, goiter, hyperthyroidism, hypothyroidism, thyroiditis, thyroid and pituitary cancer, thyroid hormone resistance, diabetes, hypopituitarism, parathyroid gland disorders, osteoporosis and rickets; Pharmaceutical preparations for the treatment of metabolic diseases and disorders, namely diabetes, hypoglycaemia, gout, osteoarthritis, muscular dystrophy, anemia; pharmaceutical preparations for the treatment of metabolic disorders, namely diabetes, bulimia nervosa, anorexia, obesity and hypothyroidism; pharmaceutical preparations for the treatment of psychiatric diseases, namely mood disorders, anxiety disorders, cognitive disorders; pharmaceutical preparations for the treatment of the central nervous system, namely, central nervous system infections, brain diseases, brain injury, central nervous system movement disorders, ocular motility disorders, spinal cord diseases; pharmaceutical preparations for use in ocular disorders and ophthalmology; pharmaceutical preparations for the treatment of eye injuries; pharmaceutical preparations for the treatment of ear infections and mastoid process diseases; pharmaceutical preparations for the treatment of ear injuries; pharmaceutical preparations for the treatment of cardiovascular diseases; pharmaceutical preparations for the treatment of the respiratory system; pharmaceutical preparations for use in gastroenterology; pharmaceutical preparations for the treatment of dental and oral diseases; pharmaceutical preparations for the treatment of dental injuries; pharmaceutical preparations for use in dermatology, namely, dermatitis, skin pigmentation diseases, skin injuries; sexually transmitted diseases; pharmaceutical preparations for the treatment of the musculoskeletal system, namely connective tissue diseases, bone diseases, spinal diseases, spinal cord injuries, back pain, fractures, sprains, bone and skull injuries, and cartilage injuries; pharmaceutical preparations for the treatment of genitourinary diseases, namely urological diseases, infertility, sexually transmitted diseases, inflammatory pelvic diseases; pharmaceutical preparations for the treatment of disorders in pregnancy, childbirth and the puerperium; pharmaceutical preparations for fertility; pharmaceutical preparations for the treatment of congenital malformations, deformations, and chromosomal abnormalities